Pancreatic Cancer Research

ResearcherHumanitas UniversityActive in the last 2 years

Giovanni Carlo Ferrari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5405-9046; OpenAlex author ID A5103113899. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
55
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 3 papers · 2025: 4 papers · 2026: 2 papers

Papers 13

  1. Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
  2. Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3↗
  3. Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. Co-author DOI 10.1001/jamasurg.2025.4054↗
  4. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  5. Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.suronc.2025.102208↗
  6. Artery-First Approach During Minimally Invasive Pancreatoduodenectomy for Pancreatic Cancer: Outcomes from a Single Center and Comparison Between Laparoscopic … Last author DOI 10.3390/cancers17132103↗
  7. The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study. Co-author DOI 10.1016/j.suronc.2024.102081↗
  8. The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. Co-author DOI 10.1093/bjs/znae236↗
  9. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
  10. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
  11. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.01.016↗
  12. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Co-author DOI 10.1245/s10434-022-13054-2↗
  13. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial. Co-author DOI 10.1186/s13063-021-05506-z↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Zironda · 2 shared papers, 2025 · strength 0.49
  2. Michele Mazzola · 2 shared papers, 2025 · strength 0.49
  3. Tobias Keck · 2 shared papers, 2023–2024 · strength 0.25
  4. Riccardo Casadei · 2 shared papers, 2023–2024 · strength 0.25
  5. Andrea Pietrabissa · 2 shared papers, 2023–2024 · strength 0.25
  6. Bergþór Björnsson · 2 shared papers, 2023–2024 · strength 0.25
  7. Izaak Quintus Molenaar · 2 shared papers, 2023–2024 · strength 0.25
  8. Safi Dokmak · 2 shared papers, 2023–2024 · strength 0.25
  9. Thilo Hackert · 2 shared papers, 2023–2024 · strength 0.25
  10. Patricia Sánchez‐Velázquez · 2 shared papers, 2023–2024 · strength 0.25
  11. Giovanni Butturini · 2 shared papers, 2023–2024 · strength 0.25
  12. Alessandro Zerbi · 2 shared papers, 2023–2024 · strength 0.25
  13. Alessandro Esposito · 2 shared papers, 2023–2024 · strength 0.25
  14. Bas Groot Koerkamp · 2 shared papers, 2023–2024 · strength 0.25
  15. Ugo Boggi · 2 shared papers, 2023–2024 · strength 0.25
  16. Marc G. Besselink · 2 shared papers, 2023–2024 · strength 0.25
  17. Mohammad Abu Hilal · 2 shared papers, 2023–2024 · strength 0.25
  18. Davide Citterio · 1 shared paper, 2025 · strength 0.23
  19. Vincenzo Mazzaferro · 1 shared paper, 2025 · strength 0.23
  20. Samuele Grandi · 1 shared paper, 2025 · strength 0.23
  21. Giuseppe Leoncini · 1 shared paper, 2025 · strength 0.23
  22. Matteo De Pastena · 1 shared paper, 2024 · strength 0.13
  23. Svein Olav Bratlie · 1 shared paper, 2024 · strength 0.13
  24. David A. Kooby · 1 shared paper, 2024 · strength 0.13
  25. Adnan A. Alseidi · 1 shared paper, 2024 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.